New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 2, 2014
12:33 EDTAPOL, XLRN, MON, LQDT, MNKD, CELG, AGUOn The Fly: Midday Wrap
Stocks on Wall Street were slightly higher at midday after payroll provider ADP estimated that employers added 191K jobs in March. The jobs addition was slightly less than expected, but a figure near 200K still may add confidence that Friday's jobs report from the Department of Labor may be an encouraging one. ECONOMIC EVENTS: ADP estimated that private payrolls increased 191K in March, which fell just short of the 193K consensus estimate. Factory orders grew by 1.6% in February, versus expectations for an increase of 1.2% in the month. COMPANY NEWS: Agribusiness giant Monsanto (MON) rose 1.5% after reporting better than expected earnings and revenue for its just-completed second quarter and confirming its fiscal year profit guidance. Another agricultural products maker, fertilizer producer Agrium (AGU), slid over 2% after warning that the late spring season this year is expected to impact the timing of its wholesale, and to a lesser extent its retail, earnings. MAJOR MOVERS: Among the notable gainers was MannKind (MNKD), which surged more than 77% after an FDA advisory panel voted to recommend its Afrezza inhalation powder to treat type 1 and type 2 diabetes. Also higher was Acceleron Pharma (XLRN), which rose 15% after its larger partner Celgene (CELG) reached a deal to raise its stake in Acceleron to 14.8% by acquiring 1.1M Acceleron shares from five current stockholders. Among the noteworthy losers was Liquidity Services (LQDT), which dropped 11% after RW Baird said the company's high bid for the Non-Rolling Stock portion of the Defense Logistics Agency’s surplus liquidation contract is "quite a bit" higher than it expected. Also lower was Apollo Education (APOL), which fell 8% near noon despite an upgrade of its shares at Wells Fargo after the company's Q2 revenue missed expectations and it also disclosed the receipt of a subpoena by its University of Phoenix unit from the Office of the Inspector General of the U.S. Department of Education. INDEXES: Near midday, the Dow was up 19.39, or 0.12%, to 16,552.00, the Nasdaq was up 5.39, or 0.13%, to 4,273.43, and the S&P 500 was up 4.81, or 0.26%, to 1,890.33.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
November 18, 2015
09:57 EDTMONMonsanto sees FY16 ongoing EPS $5.10-$5.60, consensus $5.33
Expects FY16 Seeds & Genomics mid-to-high single digit growth in gross profit. Sees Agriculture productivity gross profit of $900M-$1.1B. Sees FY16 operating expense to be up 2%-4% inclusive of new platform of investment. Sees FY16 tax rate of 25%-27%.
09:55 EDTMONMonsanto plans to continue to target 1.5x net debt to ongoing EBITDA ratio
Subscribe for More Information
09:54 EDTMONMonsanto expects core pipeline to deliver up to $25B of peak net sales
The company said innovation is expected to underpin 80% of the gross profit growth to 2019. It expects the company is tracking toward the 3rd straight year of greater than 20 pipeline advancements. Comments taken from slides for Monsanto Biennial Investor Event.
06:03 EDTMONBayer says not looking to sell crop chemicals business, Reuters reports
Bayer (BAYRY) says its Bayer CropScience unit is an "integral part" of the company and that the division is not for sale, Reuters reports. Bayer's comments come after Monsanto (MON) executives said that it is in internal discussions about tie-ups in the industry. Reference Link
06:01 EDTMONMonsanto studying possibility for consolidation in agrochem sector, Reuters says
Subscribe for More Information
November 17, 2015
16:26 EDTMONOn The Fly: Top stock stories for Tuesday
Stocks on Wall Street see-sawed throughout the day and eventually finished the day mixed, with solid earnings reports from both Wal-Mart (WMT) and Home Depot (HD) helping the Dow notch a small gain while the S&P recorded a small loss. The averages looked to be set to extend yesterday's advance, but weakened during the afternoon following news of a stadium evacuation in Europe that unsettled investors and put a halt to the rally. The market struggled into the close but avoided a big selloff as headlines crossed that police in Germany found no explosives at the site of the game cancellation in Hanover. ECONOMIC EVENTS: In the U.S., the consumer price index rose 0.2% in October, as expected. When food and energy prices are stripped out, the "core" CPI also rose 0.2%, also matching the consensus forecast. Industrial production slid 0.2% in October, versus expectations for it to have risen 0.1%. Capacity utilization came in as expected at 77.5%. NAHB's home builder sentiment index fell 3 points to 62 in November, versus expectations for a reading of 64. COMPANY NEWS: Shares of Wal-Mart advanced 3.5% to $59.92 after the world's largest retailer reported better than expected quarterly earnings and gave a fiscal year profit outlook that was higher than expected at the midpoint of the company's range. Another retail giant and fellow Dow member, Home Depot, gained 4.4% to $126.18 while TJX (TJX), owner of the TJ Maxx and HomeGoods brands, rose nearly 4% to $68.18 after their own better than expected quarterly reports. Missing out on the retail rally, however, was Dick's Sporting Good (DKS), which tumbled 9.4% to $36.96 after giving guidance for the holiday quarter and fiscal 2015 that missed consensus estimates. MAJOR MOVERS: Among the notable gainers was Airgas (ARG), which jumped $31.17, or 29.39%, to $137.35 after agreeing to be acquired by Air Liquide for $143 per share. Also higher was Syngenta (SYT), which advanced $6.69, or 9.24%, to $79.06 after Monsanto (MON) Chief Operating Officer Brett Begemann told reporters the company is weighing another attempt at acquiring the Swiss firm. Among the noteworthy losers were GNC (GNC), Vitamin Shoppe (VSI), and Natural Health (NHTC), which dropped a respective 6.4%, 5%, and 15.4% after the Department of Justice said in a media advisory that it would announce actions related to dietary supplements sales and unlawful ads. Shares in the publicly traded companies came off their lows, but did not fully recover heading into the close, after the agency announced that its criminal case was charging USPlabs and that its five civil cases were against a number of smaller businesses. Also lower was SunEdison (SUNE), which fell $1.54, or 33.74%, to $3.02, with Oppenheimer attributing the selloff to "unsubstantiated rumors" regarding its liquidity and Deutsche Bank saying language in Vivint Solar's (VSLR) quarterly filing around SunEdison debt financing could concern some investors who are focused on the balance sheet. Additionally, Adeptus (ADPT) declined 22.3% to $46.50 after an NBC affiliate published an investigative report scrutinizing billing practices at freestanding emergency rooms in Colorado. INDEXES: The Dow rose 6.49, or 0.04%, to 17,489.50, the Nasdaq gained 1.40, or 0.03%, to 4,986.02, and the S&P 500 slipped 2.75, or 0.13%, to 2,050.44.
13:19 EDTMONMonsanto weighs another takeover offer for Syngenta, Bloomberg reports
Monsanto (MON) is weighing another takeover attempt for Syngenta (SYT) after China National Chemical Corporation made an offer for Syngenta, Bloomberg reports. Monsanto is having internal discussions over the benefits of a new offer, the report says, citing comments from COO Brett Begemann in front of reporters in St. Louis. Reference Link
12:54 EDTMONMonsanto targets over 1.3B acres of technology upgrades from platforms by 2025
During Monsanto company's Biennial Investor Event, the company will note that it operates from a global footprint of more than 400M acres currently using its technologies, with the company anticipating more than 1.3B acres of next-generation technology upgrades by 2025. Approximately 800M acres of upgrades are expected to come from its core growth drivers like Intacta RR2 PRO soybeans, Roundup Ready 2 Xtend soybeans and from its global corn portfolio. The company anticipates another 550M-900M acres of technology upgrades from its new growth platforms, including 300M-400M acres from the Climate FieldView digital agronomic platform and 250M-500M acres from the BioAg Alliance with Novozymes.
12:51 EDTMONMonsanto sees more than 20% CAGR in ongoing EPS from end of FY16 to FY19
Subscribe for More Information
12:48 EDTMONMonsanto confirms FY16 EPS view of $5.10-$5.60, consensus $5.33
Subscribe for More Information
11:34 EDTMONMonsanto to host two day biennial investor event
Subscribe for More Information
11:27 EDTMONMonsanto still sees earnings doubling by 2019, Bloomberg reports
Monsanto (MON) COO Brett Begemann told reporters ahead of the company's biennial investor event tomorrow that his company still expects its earnings to double between 2014 and 2019, according to Bloomberg. Begemann added that Monsanto management is internally discussing making another takeover approach to Syngenta (SYT), the news agency added. Begemann noted that acquisitions are not needed for Monsanto to double earnings by 2019. He expects 20% earnings growth in 2017, 2018 and 2019, Bloomberg reports.
11:24 EDTMONSyngenta jumps 3% after Monsanto says discussing another approach
Subscribe for More Information
11:23 EDTMONMonsanto COO says internally discussing another Syngenta approach
Subscribe for More Information
08:22 EDTCELGSignificant Celgene overhang removed, says JMP Securities
Subscribe for More Information
November 16, 2015
17:10 EDTMONSoros took stake in Paypal, liquidated Herbalife stake
Soros Fund Management gave a quarterly update on its stakes in a filing this afternoon. NEW STAKES: Paypal (PYPL), CIT Group (CIT), Schlumberger (SLB), Kraft Heinz (KHC), and Amazon (AMZN). INCREASED STAKES: Allergan (AGN), Lions Gate (LGF), Energen (EGN), Southwest Airlines (LUV), and Qunar Cayman Islands (QUNR). DECREASED STAKES: LyondellBasell (LYB), YPF (YPF), Time Warner Cable (TWC), Dow Chemical (DOW), and Monsanto (MON). LIQUIDATED STAKES: Herbalife (HLF), Lennar (LEN), DR Horton (DHI), United Continental (UAL), and Nice Systems (NICE).
13:11 EDTCELGCelgene jumps 2% after defeating Kyle Bass patent challenge
Shares of Celgene moved higher after the U.S. Patent and Trademark Office declined to review a Revlimid patent expiring in 2019. The USPTO found that that Bass's Coalition for Affordable Drugs was unlikely to succeed, according to Bloomberg. Shares of Celgene are up 2%, or $1.64, to $190.13 in afternoon trading. The agency is reviewing two other patents on the drug.
13:08 EDTCELGCelgene defeats Bass challenege on Revlimid patent, Bloomberg reports
Subscribe for More Information
10:00 EDTMNKDOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Abengoa (ABGB) downgraded to Hold from Buy at Canaccord... Best Buy (BBY) downgraded to Sector Perform from Outperform at RBC Capital... CDTi (CDTI) downgraded to Neutral from Buy at Roth Capital... CNH Industrial (CNHI) downgraded to Underweight from Neutral at JPMorgan... Clayton Williams (CWEI) downgraded to Sell from Neutral at Roth Capital... Disney (DIS) downgraded to Neutral from Buy at Guggenheim... Endo (ENDP) downgraded to Neutral from Buy at Mizuho... Five Below (FIVE) downgraded to Hold from Buy at Deutsche Bank... Garrison Capital (GARS) downgraded to Market Perform from Outperform at William Blair... General Growth (GGP) downgraded to Hold from Buy at Evercore ISI... Helmerich & Payne (HP) downgraded to Hold from Buy at Evercore ISI... Kosmos (KOS) downgraded on investor sentiment, costs at RBC Capital... MannKind (MNKD) downgraded to Neutral from Buy at Griffen Securities... Media General (MEG) downgraded to Hold from Buy at Evercore ISI... Progressive (PGR) downgraded to Sell from Neutral at Goldman... Sabra Health Care (SBRA) downgraded on challenges, investor sentiment at Stifel... Simon Property (SPG) downgraded to Hold from Buy at Evercore ISI... Springleaf (LEAF) downgraded after settlement on acquisition reached at BMO Capital... Steiner Leisure (STNR) downgraded to Market Perform from Outperform at William Blair... Taubman Centers (TCO) downgraded to Hold from Buy at Evercore ISI... TerraForm Power (TERP) downgraded to Neutral from Buy at UBS... UniCredit (UNCFF) downgraded to Neutral from Buy at Citi... Violin Memory (VMEM) downgraded to Hold from Buy at Maxim... Vipshop (VIPS) downgraded to Equal Weight from Overweight at Morgan Stanley... Wolseley (WOSYY) downgraded to Hold from Buy at Deutsche Bank.
08:39 EDTMNKDMannKind downgraded to Neutral from Buy at Griffen Securities
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use